This GE Aerospace Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
BioAge Labs, Inc.
Dave, Inc. Class A
GE Aerospace
Century Therapeutics, Inc.
RED CAT HOLDINGS
BioAge Labs, Inc. BIOA | 0.00 | |
Dave, Inc. Class A DAVE | 0.00 | |
GE Aerospace GE | 0.00 | |
Century Therapeutics, Inc. IPSC | 0.00 | |
RED CAT HOLDINGS RCAT | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Mizuho analyst Salim Syed initiated coverage on Century Therapeutics Inc (NASDAQ:IPSC) with an Outperform rating and announced a price target of $8. Century Therapeutics shares closed at $2.17 on Tuesday. See how other analysts view this stock.
- Roth Capital analyst Adam Walsh initiated coverage on BIOAGE Labs Inc (NASDAQ:BIOA) with a Buy rating and announced a price target of $36. Bioage Labs shares closed at $16.20 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Amit Dayal initiated coverage on Red Cat Holdings Inc (NASDAQ:RCAT) with a Buy rating and announced a price target of $20. Red Cat shares closed at $9.77 on Tuesday. See how other analysts view this stock.
- Seaport Global analyst Richard Safran initiated coverage on GE Aerospace (NYSE:GE) with a Buy rating and announced a price target of $375. GE Aerospace shares closed at $314.49 on Tuesday. See how other analysts view this stock.
- Evercore ISI Group analyst Adam Frisch initiated coverage on Dave Inc (NASDAQ:DAVE) with an In-Line rating and announced a price target of $260. Dave shares closed at $249.35 on Tuesday. See how other analysts view this stock.
Considering buying GE stock? Here’s what analysts think:
Photo via Shutterstock